Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AIOctober 27, 2026

BBH VanEck Biotech ETF

Fund tearsheet · data as of the latest session · October 27, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$502Mfund assets
+30.7%return, YTD
—return, 1 year
+$10Mnet flow, 1 month
+$16Mnet flow, 1 year
22.3%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
1AMGN AMGEN16.31%
2GILD GILEAD SCIENCES13.68%
3VRTX VERTEX PHARMACEUTICALS8.17%
4REGN REGENERON PHARMACEUTICALS6.84%
5MRNA MODERNA6.25%
6NTRA NATERA4.77%
7IQV IQVIA HOLDINGS4.60%
8ARGX ARGENX SE4.15%
9ILMN ILLUMINA3.95%
10RVMD REVOLUTION MEDICINES3.81%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.